Immunitybio Inc
Biotechnology
Healthcare
IBRX
853 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
2.64
52 week high
6.17
high
2.67
52 week low
0.00
low
2.57
growth
-26.42 %
previous Close
2.67
P/E ratio
market cap
2.28 B
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
33.33 %
eps surprise
9.09 %
net profit margin
0.00 %
784.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top